Comparisson of two epidural drugs in day-case surgery
Phase 1
Active, not recruiting
- Conditions
- Patients scheduled for ambulatory knee arthroscopy surgery receive one of the two spinal anaestheticsTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
- Registration Number
- EUCTR2015-001944-13-NL
- Lead Sponsor
- Zaans Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- 175
Inclusion Criteria
-Scheduled ambulatory knee arthroscopy
-Age = 18 years
-ASA physical status I- II
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 175
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
-Allergy to one of the study drugs
-Contraindication to neuraxial anaesthesia
-Previous neuropathy to the lower extremities
-Pregnancy
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms differentiate chloroprocaine and prilocaine in spinal anesthesia for ambulatory knee arthroscopy?
How does EUCTR2015-001944-13-NL compare chloroprocaine and prilocaine efficacy in day-case surgery recovery profiles?
Are there biomarkers predicting response to chloroprocaine or prilocaine in patients undergoing ambulatory knee arthroscopy?
What adverse events are reported in EUCTR2015-001944-13-NL for chloroprocaine versus prilocaine spinal anesthesia?
How do chloroprocaine and prilocaine compare to other amide local anesthetics like bupivacaine in day-case spinal anesthesia trials?